APA (7th ed.) Citation

MMP, S., AC, S., TY, C., PM, J., JC, H., MB, H., . . . JC, P. (2019). Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift. Oncotarget, 10(4), 449. https://doi.org/10.18632/oncotarget.26533

Chicago Style (17th ed.) Citation

MMP, Speirs, et al. "Imbalanced Sphingolipid Signaling Is Maintained as a Core Proponent of a Cancerous Phenotype in Spite of Metabolic Pressure and Epigenetic Drift." Oncotarget 10, no. 4 (2019): 449. https://doi.org/10.18632/oncotarget.26533.

MLA (9th ed.) Citation

MMP, Speirs, et al. "Imbalanced Sphingolipid Signaling Is Maintained as a Core Proponent of a Cancerous Phenotype in Spite of Metabolic Pressure and Epigenetic Drift." Oncotarget, vol. 10, no. 4, 2019, p. 449, https://doi.org/10.18632/oncotarget.26533.